title: Letter: the therapeutic potential of targeting CCL25/CCR9 in colonic inflammatory bowel disease - reading between the lines.
authors.affiliation: National Institute of Health Research (NIHR) Birmingham, Liver Biomedical Research Unit (BRU), Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. p.j.trivedi@bham.ac.uk.|Liver Unit, University Hospitals Birmingham Queen Elizabeth, Birmingham, UK. p.j.trivedi@bham.ac.uk.
authors.forename: P J
authors.initials: PJ
authors.lastname: Trivedi
authors.affiliation: Department of Internal Medicine IV, Gastroenterology, Hepatology, and Infectious Diseases, Jena University Hospital, Jena, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Schmidt
authors.affiliation: Department of Internal Medicine IV, Gastroenterology, Hepatology, and Infectious Diseases, Jena University Hospital, Jena, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Bruns
mesh_terms: D019742:Chemokines, CC; D003106:Colon; D006801:Humans; D015212:Inflammatory Bowel Diseases
chemical_list: D019742:Chemokines, CC